Literature DB >> 11563438

Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.

Y Y Hsu1, A T Du, N Schuff, M W Weiner.   

Abstract

This article reviews recent studies of magnetic resonance imaging and magnetic resonance spectroscopy in dementia, including Alzheimer's disease, frontotemporal dementia, dementia with Lewy bodies, idiopathic Parkinson's disease, Huntington's disease, and vascular dementia. Magnetic resonance imaging and magnetic resonance spectroscopy can detect structural alteration and biochemical abnormalities in the brain of demented subjects and may help in the differential diagnosis and early detection of affected individuals, monitoring disease progression, and evaluation of therapeutic effect.

Entities:  

Mesh：

Year:  2001        PMID： 11563438      PMCID： PMC1857299          DOI： 10.1177/089198870101400308

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN： 0891-9887            Impact factor:   2.680


  308 in total

1.  Midline cerebral morphometry distinguishes frontotemporal dementia and Alzheimer's disease.

Authors:  D I Kaufer; B L Miller; L Itti; L A Fairbanks; J Li; J Fishman; J Kushi; J L Cummings
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

2.  Selective cortical and hippocampal volume correlates of Mattis Dementia Rating Scale in Alzheimer disease.

Authors:  R Fama; E V Sullivan; P K Shear; L Marsh; J A Yesavage; J R Tinklenberg; K O Lim; A Pfefferbaum
Journal:  Arch Neurol       Date:  1997-06

3.  Evaluation of fasudil hydrochloride treatment for wandering symptoms in cerebrovascular dementia with 31P-magnetic resonance spectroscopy and Xe-computed tomography.

Authors:  S Kamei; M Oishi; T Takasu
Journal:  Clin Neuropharmacol       Date:  1996-10       Impact factor: 1.592

Review 4.  N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain.

Authors:  D L Birken; W H Oldendorf
Journal:  Neurosci Biobehav Rev       Date:  1989       Impact factor: 8.989

5.  Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease: a pilot study.

Authors:  G T Harvey; J Hughes; I G McKeith; R Briel; C Ballard; A Gholkar; P Scheltens; R H Perry; P Ince; J T O'Brien
Journal:  Psychol Med       Date:  1999-01       Impact factor: 7.723

6.  Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.

Authors:  K Juottonen; M Lehtovirta; S Helisalmi; P J Riekkinen; H Soininen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-09       Impact factor: 10.154

7.  SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele.

Authors:  M Lehtovirta; H Soininen; M P Laakso; K Partanen; S Helisalmi; A Mannermaa; M Ryynänen; J Kuikka; P Hartikainen; P J Riekkinen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

8.  Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease.

Authors:  S Lehéricy; M Baulac; J Chiras; L Piérot; N Martin; B Pillon; B Deweer; B Dubois; C Marsault
Journal:  AJNR Am J Neuroradiol       Date:  1994-05       Impact factor: 3.825

9.  Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population.

Authors:  K Amar; S MacGowan; G Wilcock; T Lewis; M Scott
Journal:  Int J Geriatr Psychiatry       Date:  1998-09       Impact factor: 3.485

10.  Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease.

Authors:  P Christiansen; A Schlosser; O Henriksen
Journal:  Magn Reson Imaging       Date:  1995       Impact factor: 2.546
View more
  8 in total

1.  MR imaging anatomy in neurodegeneration: a robust volumetric parcellation method of the frontal lobe gyri with quantitative validation in patients with dementia.

Authors:  B Iordanova; D Rosenbaum; D Norman; M Weiner; C Studholme
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

2.  Robust analysis of short echo time (1)H MRSI of human brain.

Authors:  X P Zhu; K Young; A Ebel; B J Soher; L Kaiser; G Matson; W M Weiner; N Schuff
Journal:  Magn Reson Med       Date:  2006-03       Impact factor: 4.668

3.  Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.

Authors:  Xiaoping Zhu; Norbert Schuff; John Kornak; Brian Soher; Kristine Yaffe; Joel H Kramer; Frank Ezekiel; Bruce L Miller; William J Jagust; Michael W Weiner
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Apr-Jun       Impact factor: 2.703

4.  High field magnetic resonance microscopy of the human hippocampus in Alzheimer's disease: quantitative imaging and correlation with iron.

Authors:  Vijay Antharam; Joanna F Collingwood; John-Paul Bullivant; Mark R Davidson; Saurav Chandra; Albina Mikhaylova; Mary E Finnegan; Christopher Batich; John R Forder; Jon Dobson
Journal:  Neuroimage       Date:  2011-08-16       Impact factor: 6.556

5.  Posterior cingulate metabolic changes in frontotemporal lobar degeneration detected by magnetic resonance spectroscopy.

Authors:  O Kizu; K Yamada; H Ito; T Nishimura
Journal:  Neuroradiology       Date:  2004-02-28       Impact factor: 2.804

6.  Evidence of neurodegeneration in brains of older adults who do not yet fulfill MCI criteria.

Authors:  L L Chao; S G Mueller; S T Buckley; K Peek; S Raptentsetseng; J Elman; K Yaffe; B L Miller; J H Kramer; C Madison; D Mungas; N Schuff; M W Weiner
Journal:  Neurobiol Aging       Date:  2008-06-11       Impact factor: 4.673

Review 7.  Mild cognitive impairment: conceptual issues and structural and functional brain correlates.

Authors:  Andrew J Saykin; Heather A Wishart
Journal:  Semin Clin Neuropsychiatry       Date:  2003-01

8.  No Acute Effects of Choline Bitartrate Food Supplements on Memory in Healthy, Young, Human Adults.

Authors:  D P Lippelt; S van der Kint; K van Herk; M Naber
Journal:  PLoS One       Date:  2016-06-24       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.